NCT06587490View on ClinicalTrials.gov

Total RadIoTherapy of Oligometastatic caNcerS

PHASE3RecruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

November 12, 2024

Primary Completion Date

November 30, 2033

Study Completion Date

November 30, 2034

Conditions
Oligometastatic Malignant Solid Neoplasm
Interventions
RADIATION

stereotactic ablative radiotherapy

Stereotactic ablative radiotherapy is a highly focused radiation treatment that gives an intense dose of radiation concentrated on a tumor, while limiting the dose to the surrounding organs.

Trial Locations (1)

92093

RECRUITING

University of California, San Diego, La Jolla

All Listed Sponsors
lead

University of California, San Diego

OTHER